sponsored
Type 2 diabetes treatment plans: understanding dealbreakers for patients
A case study on patient preferences and shared decision-making
This content has been independently produced by ADG, make possible through sponsorship from Boehringer Ingelheim
By Dr Gary Kilov
Case study introduction
Patient preference should be a major factor in driving the choice of glucose-lowering medications to treat type 2 diabetes.
For some people, the route of administration is key to compliance, especially for those with a fear of injections or conversely, a tendency to be non-adherent to daily oral medication.
Others worry about potential
